Association between PNPLA3 and TM6SF2 gene polymorphisms and non-alcoholic fatty liver disease patients in Kazakhstan

Keyphrases

• 21st Century 14%
• Bacterial Genome 14%
• Biochip 14%
• Clinical Assessment 14%
• Clinical Laboratory 14%
• Differences between Groups 28%
• Disease Stage 14%
• Female Patients 14%
• Fibroscan 14%
• GC Genotype 14%
• Gene Polymorphism 100%
• Genetic Background 14%
• Genome-wide Association Study 14%
• Gut Microbiome Analysis 28%
• Gut Microbiota 14%
• HBV Infection 14%
• Heavy Alcohol Consumption 14%
• Hepatitis C Virus Infection 14%
• Hepatocellular Carcinoma 14%
• High Risk 14%
• Ion Torrent Sequencing 14%
• Kazakhstan 100%
• Laboratory Markers 14%
• Large Intestine 14%
• Large Sample Size 14%
• Liver Disease 28%
• Liver Disease Progression 14%
• Liver Fibrosis 14%
• Liver Function Tests 14%
• Metabolic Panel 14%
• Microbial Composition 14%
• Non-alcoholic Fatty Liver Disease (NAFLD) 100%
• Nucleotide Variability 14%
• PNPLA3 100%
• PNPLA3 Gene 14%
• Positive Contributions 14%
• Statistically Significant Difference 57%
• Steatosis 28%
• Targeted Gene 14%
• Total Cholesterol 14%
• Transmembrane 6 Superfamily Member 2 (TM6SF2) 100%

INIS

• adults 11%
• alcohols 11%
• assessments 11%
• children 11%
• cholesterol 11%
• diseases 100%
• fibrosis 11%
• genes 100%
• genetics 11%
• genotype 11%
• hepatitis 11%
• hepatomas 11%
• kazakhstan 100%
• laboratories 22%
• large intestine 11%
• liver 100%
• men 11%
• nucleotides 11%
• panels 11%
• patients 100%
• pcr 11%
• risks 11%
• semiconductor materials 11%
• size 11%
• values 11%
• viruses 11%
• women 11%

Biochemistry, Genetics and Molecular Biology

• Bacterial Genome 16%
• Biochip 16%
• Cholesterol Blood Level 16%
• Gene Polymorphism 100%
• Genetic Background 16%
• Genome-Wide Association Study 16%
• Genotyping 66%
• Gut Microbiome 50%
• Hepatitis B Virus 16%
• Hepatitis C Virus 16%
• Large Intestine 16%
• Liver Function Test 16%
• Microbiome 16%
• Nucleotide 16%
• PNPLA3 100%
• Sample Size 16%